MCL1 and acute myeloid leukemia: Results of Pei et al.[167] suggest that resistance to the azacitidine/venetoclax doublet is mediated by the presence of monocytic AML cells, which upregulate MCL1 to evade BCL2 blockade and relieve mitochondrial energetic stress.